CDC-Authored Genomics and Precision Health Publications Database
Last data update: Nov 04, 2024. (Total: 6390 publications)
Query Trace: Britton A[original query] |
---|
Risk of clade II mpox associated with intimate and nonintimate close contact among men who have sex with men and transgender adults - United States, August 2022-July 2023
Chard AN , Dalton AF , Diallo AO , Moulia DL , Deputy NP , Zecca IB , Quilter LAS , Kachur RE , McCollum AM , Rowlands JV , Britton AN , Fisher R , Chai SJ , Licherdell E , Still WL , Morris AL , Castilho JL , Markus TM , Morrow AS , Danza P , Hansen AP , Ali SI , Wegner CW , Weber R , Betancourt GS , Zipprich J , Sutton M , Pathela P , Hawkins S , Wendel KA , Feldstein LR . MMWR Morb Mortal Wkly Rep 2024 73 (40) 896-902 |
Regulatory elements in SEM1-DLX5-DLX6 (7q21.3) locus contribute to genetic control of coronal nonsyndromic craniosynostosis and bone density-related traits
Nicoletti P , Zafer S , Matok L , Irron I , Patrick M , Haklai R , Evangelista JE , Marino GB , Ma'ayan A , Sewda A , Holmes G , Britton SR , Lee WJ , Wu M , Ru Y , Arnaud E , Botto L , Brody LC , Byren JC , Caggana M , Carmichael SL , Cilliers D , Conway K , Crawford K , Cuellar A , Di Rocco F , Engel M , Fearon J , Feldkamp ML , Finnell R , Fisher S , Freudlsperger C , Garcia-Fructuoso G , Hagge R , Heuzé Y , Harshbarger RJ , Hobbs C , Howley M , Jenkins MM , Johnson D , Justice CM , Kane A , Kay D , Gosain AK , Langlois P , Legal-Mallet L , Lin AE , Mills JL , Morton JEV , Noons P , Olshan A , Persing J , Phipps JM , Redett R , Reefhuis J , Rizk E , Samson TD , Shaw GM , Sicko R , Smith N , Staffenberg D , Stoler J , Sweeney E , Taub PJ , Timberlake AT , Topczewska J , Wall SA , Wilson AF , Wilson LC , Boyadjiev SA , Wilkie AOM , Richtsmeier JT , Jabs EW , Romitti PA , Karasik D , Birnbaum RY , Peter I . Genet Med Open 2024 2 |
Select gut microbiota impede rotavirus vaccine efficacy
Ngo VL , Wang Y , Wang Y , Shi Z , Britton R , Zou J , Ramani S , Jiang B , Gewirtz AT . Cell Mol Gastroenterol Hepatol 2024 101393 |
Evaluating immunologic and illness outcomes of SARS-CoV-2 infection in vaccinated and unvaccinated children aged ≥ 5 years, in a multisite longitudinal cohort
Porter C , Lyski ZL , Uhrlaub JL , Ellingson KD , Jeddy Z , Gwynn L , Rivers P , Sprissler R , Hegmann KT , Coughlin MM , Fowlkes AL , Hollister J , LeClair L , Mak J , Beitel SC , Fuller S , Zheng PQ , Vaughan M , Rai RP , Grant L , Newes-Adeyi G , Yoo YM , Olsho L , Burgess JL , Caban-Martinez AJ , Yoon SK , Britton A , Gaglani M , Phillips AL , Thiese MS , Hagen MB , Jones JM , Lutrick K . Diseases 2024 12 (8) |
Effectiveness of bivalent mRNA COVID-19 vaccines in preventing SARS-cov-2 infection in children and adolescents aged 5 to 17 years
Feldstein LR , Britton A , Grant L , Wiegand R , Ruffin J , Babu TM , Briggs Hagen M , Burgess JL , Caban-Martinez AJ , Chu HY , Ellingson KD , Englund JA , Hegmann KT , Jeddy Z , Lauring AS , Lutrick K , Martin ET , Mathenge C , Meece J , Midgley CM , Monto AS , Newes-Adeyi G , Odame-Bamfo L , Olsho LEW , Phillips AL , Rai RP , Saydah S , Smith N , Steinhardt L , Tyner H , Vandermeer M , Vaughan M , Yoon SK , Gaglani M , Naleway AL . Jama 2024 331 (5) 408-416 |
Early estimates of updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection attributable to co-circulating Omicron variants among immunocompetent adults - increasing community access to testing program, United States, September 2023-January 2024
Link-Gelles R , Ciesla AA , Mak J , Miller JD , Silk BJ , Lambrou AS , Paden CR , Shirk P , Britton A , Smith ZR , Fleming-Dutra KE . MMWR Morb Mortal Wkly Rep 2024 73 (4) 77-83 |
Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions
Link-Gelles R , Britton A , Fleming-Dutra KE . Vaccine 2023 |
Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023
Plumb ID , Briggs Hagen M , Wiegand R , Dumyati G , Myers C , Harland KK , Krishnadasan A , James Gist J , Abedi G , Fleming-Dutra KE , Chea N , Lee JE , Kellogg M , Edmundson A , Britton A , Wilson LE , Lovett SA , Ocampo V , Markus TM , Smithline HA , Hou PC , Lee LC , Mower W , Rwamwejo F , Steele MT , Lim SC , Schrading WA , Chinnock B , Beiser DG , Faine B , Haran JP , Nandi U , Chipman AK , LoVecchio F , Eucker S , Femling J , Fuller M , Rothman RE , Curlin ME , Talan DA , Mohr NM . Vaccine 2023 |
Humoral immune response to messenger RNA coronavirus disease 2019 vaccination among children aged 5-11 years in a multisite prospective cohort study, September 2021-September 2022
Lyski ZL , Porter C , Uhrlaub JL , Ellingson KD , Jeddy Z , Gwynn L , Rivers P , Sprissler R , Hegmann KT , Coughlin M , Fowlkes A , Hollister J , LeClair L , Mak J , Beitel SC , Fuller S , Grant L , Newes-Adeyi G , Yoo YM , Olsho L , Burgess JL , Caban-Martinez A , Yoon S , Britton A , Gaglani M , Lutrick K . Open Forum Infect Dis 2023 10 (8) ofad431 |
Interim recommendations for use of bivalent mRNA COVID-19 vaccines for persons aged 6 months - United States, April 2023
Moulia DL , Wallace M , Roper LE , Godfrey M , Rosenblum HG , Link-Gelles R , Britton A , Daley MF , Meyer S , Fleming-Dutra KE , Oliver SE , Twentyman E . MMWR Morb Mortal Wkly Rep 2023 72 (24) 657-662 |
Effectiveness of booster doses of monovalent mRNA COVID-19 vaccine against symptomatic severe acute respiratory syndrome coronavirus 2 infection in children, adolescents, and adults during omicron subvariant BA.2/BA.2.12.1 and BA.4/BA.5 predominant periods
Ciesla AA , Wiegand RE , Smith ZR , Britton A , Fleming-Dutra KE , Miller J , Accorsi EK , Verani JR , Shang N , Derado G , Pilishvili T , Link-Gelles R . Open Forum Infect Dis 2023 10 (5) ofad187 |
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
Link-Gelles R , Ciesla AA , Roper LE , Scobie HM , Ali AR , Miller JD , Wiegand RE , Accorsi EK , Verani JR , Shang N , Derado G , Britton A , Smith ZR , Fleming-Dutra KE . MMWR Morb Mortal Wkly Rep 2023 72 (5) 119-124 |
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
Britton A , Embi PJ , Levy ME , Gaglani M , DeSilva MB , Dixon BE , Dascomb K , Patel P , Schrader KE , Klein NP , Ong TC , Natarajan K , Hartmann E , Kharbanda AB , Irving SA , Dickerson M , Dunne MM , Raiyani C , Grannis SJ , Stenehjem E , Zerbo O , Rao S , Han J , Sloan-Aagard C , Griggs EP , Weber ZA , Murthy K , Fadel WF , Grisel N , McEvoy C , Lewis N , Barron MA , Nanez J , Reese SE , Mamawala M , Valvi NR , Arndorfer J , Goddard K , Yang DH , Fireman B , Ball SW , Link-Gelles R , Naleway AL , Tenforde MW . MMWR Morb Mortal Wkly Rep 2022 71 (42) 1335-1342 |
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
Fleming-Dutra KE , Britton A , Shang N , Derado G , Link-Gelles R , Accorsi EK , Smith ZR , Miller J , Verani JR , Schrag SJ . JAMA 2022 327 (22) 2210-2219 |
Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
Britton A , Fleming-Dutra KE , Shang N , Smith ZR , Dorji T , Derado G , Accorsi EK , Ajani UA , Miller J , Schrag SJ , Verani JR . JAMA 2022 327 (11) 1032-1041 |
Microbial community structure and composition is associated with host species and sex in Sigmodon cotton rats.
Strickland BA , Patel MC , Shilts MH , Boone HH , Kamali A , Zhang W , Stylos D , Boukhvalova MS , Rosas-Salazar C , Yooseph S , Rajagopala SV , Blanco JCG , Das SR . Anim Microbiome 2021 3 (1) 29 |
Expanding the malaria molecular diagnostic options: opportunities and challenges for loop-mediated isothermal amplification tests for malaria control and elimination.
Lucchi NW , Ndiaye D , Britton S , Udhayakumar V . Expert Rev Mol Diagn 2018 18 (2) 195-203 |
- Page last reviewed:Feb 1, 2024
- Content source: